Selectin antagonists (Revotar)

N/A

Report date: 2025/02/01 20:00:06
NME

Base Information

Drug NameSelectin antagonists (Revotar)
Drug Alias NameBimosiamose back-up compounds (Revotar)Selectin antagonists (Revotar)bimosiamose back-up compounds (Revotar)
ClassificationSmall molecules > Heterocyclic drugs
Mechanisms of ActionLeukocyte adhesion molecule-1 inhibitorsSelectin E inhibitorsP-selectin inhibitors
TargetsLeukocyte adhesion molecule-1P-selectinSelectin E
Therapy Area/IndicationsPsoriasisAcute Lung InjuryPulmonary Disease, Chronic Obstructive
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryGermany
CombinationsNo
Global Highest StatusPending (Preclinical)
Highest Status in ChinaN/A
Originator CompaniesRevotar Biopharmaceuticals Ag
China Registration ClassN/A

Develop Information

Active CompaniesN/A
Inactive CompaniesRevotar Biopharmaceuticals Ag
Active IndicationsN/A
Inactive IndicationsPsoriasisAcute Lung InjuryPulmonary Disease, Chronic Obstructive

Other Information

ATC CodeN/A
Related LinksN/A